Edition:
United States

VistaGen Therapeutics Inc (VTGN.OQ)

VTGN.OQ on NASDAQ Stock Exchange Capital Market

1.65USD
12:35pm EST
Change (% chg)

$-0.05 (-2.94%)
Prev Close
$1.70
Open
$1.67
Day's High
$1.69
Day's Low
$1.65
Volume
7,344
Avg. Vol
67,082
52-wk High
$2.43
52-wk Low
$0.83

Chart for

About

VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system (CNS). Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II... (more)

Overall

Beta: -0.57
Market Cap(Mil.): $17.09
Shares Outstanding(Mil.): 10.75
Dividend: --
Yield (%): --

Financials

  VTGN.OQ Industry Sector
P/E (TTM): -- 30.48 33.71
EPS (TTM): -1.36 -- --
ROI: -245.77 14.98 14.48
ROE: -415.24 16.31 15.99

Earnings vs. Estimates